PatternsRadar
Sign in

NATHBIOGENNath Bio-Genes (India) Limited

NSE
Full chart
138.31INR+4.02 (+2.99%)Close · 6 Oct 2026
29 Jul 2026Last results
FMCGSector
Agricultural Food & other ProductsIndustry
₹263 CrMarket cap
7.2P/E (TTM)
68.4%Delivery

Filings & corporate actions

50 results filed
CSV
Next results · Q2 FY27
Expected 16 Oct 2026 – 13 Nov 2026
Estimate: filed 16–44 days after quarter end, last 5 times
Dividend
₹2.00 per share · last 11 Sept 2026
2026
  • 11 SeptdividendDividend · ₹2.00 per share-3.1%
  • 29 JulresultsResults · Q1 FY27 · consolidated and standalone+0.9%NSE
  • 21 JulshareholdingShareholding · 30 Jun 2026+0.8%NSE
  • 4 MayresultsResults · Q4 FY26 · consolidated and standalone-8.4%NSE
  • 21 AprshareholdingShareholding · 31 Mar 2026-0.2%NSE
  • 31 JanresultsResults · Q3 FY26 · consolidated and standalone-1.8%NSE
  • 20 JanshareholdingShareholding · 31 Dec 2025-5.9%NSE

Reaction to results · all yearsrose on day 0 in 14 of 50 CSV

QuarterFiledDay 0+5D+20DRel vol
Q1 FY2729 Jul 2026+0.9%+0.6%-3.8%9.0×
Q4 FY264 May 2026-8.4%-13.6%-8.6%3.0×
Q3 FY2631 Jan 2026-1.8%+3.0%+1.5%1.2×
Q2 FY2613 Nov 2025+1.3%-4.3%-7.2%1.2×
Q1 FY2611 Jul 2025-5.0%-14.6%-24.1%0.3×
Q4 FY2530 Apr 2025-0.3%+2.2%+19.4%1.5×
Q3 FY2523 Jan 2025-1.8%-4.1%-10.0%1.0×
Q2 FY2523 Oct 2024-4.2%-4.6%-10.0%4.3×
Q1 FY257 Aug 2024-1.9%-5.6%-5.6%0.8×
Q4 FY248 May 2024-5.3%-6.9%-8.1%1.7×
Q3 FY2418 Jan 2024+10.5%+6.7%+5.7%17.3×
Q2 FY2416 Oct 2023-8.2%-16.6%-10.0%2.8×
Q1 FY2410 Aug 2023-1.0%-7.2%-2.1%2.6×
Q4 FY2322 Apr 2023-4.0%-2.8%-2.0%4.5×
Q3 FY2314 Feb 2023-2.4%-6.2%-3.1%1.5×
Q2 FY237 Nov 2022-0.9%-5.2%+1.7%0.7×
Q1 FY2313 Aug 2022-0.4%-3.3%-0.8%0.5×
Q4 FY2230 May 2022-8.7%-10.2%-17.4%5.8×
Q3 FY2211 Feb 2022-4.6%-9.8%-12.7%0.9×
Q2 FY221 Nov 2021-5.3%-2.9%-15.0%2.0×
Q1 FY2210 Aug 2021+2.1%-5.8%-7.2%1.6×
Q4 FY2124 Jun 2021-5.4%-8.4%-13.0%1.2×
Q3 FY2110 Feb 2021-0.3%+3.0%+12.5%0.8×
Q2 FY217 Nov 2020-4.6%-3.2%+5.1%1.8×
Q1 FY217 Aug 2020-10.6%-20.9%-28.7%6.5×
Q4 FY2015 Jun 2020+4.9%+0.9%+1.1%1.9×
Q3 FY2030 Jan 2020+0.5%-6.3%-9.4%0.5×
Q2 FY202 Nov 2019-3.9%+4.3%-9.1%2.1×
Q1 FY205 Aug 2019+2.2%-1.5%-7.6%2.4×
Q4 FY1931 May 2019-2.5%-5.9%-9.4%0.7×
Q3 FY194 Feb 2019-3.1%-10.7%+7.5%1.1×
Q2 FY1921 Nov 2018-2.0%+6.8%+5.8%0.5×
Q1 FY198 Aug 2018-1.6%-1.8%-0.8%0.7×
Q4 FY1825 Jun 2018-0.3%+0.2%+14.5%0.2×
Q3 FY1826 Feb 2018-2.2%-9.8%-15.6%0.7×
Q2 FY1831 Oct 2017-2.8%-5.2%+5.1%0.7×
Q1 FY183 Aug 2017+5.0%-11.1%+6.8%0.6×
Q4 FY177 Jun 2017+8.3%+16.2%+34.2%2.8×
Q3 FY1730 Jan 2017-1.0%+4.3%+2.3%0.9×
Q2 FY1718 Nov 2016-6.3%+11.2%+2.8%0.6×
Q1 FY176 Aug 2016+1.2%-2.2%+1.2%0.3×
Q4 FY168 Jun 2016+4.3%+3.0%+14.8%5.5×
Q3 FY161 Feb 2016-4.7%-14.5%-18.3%0.3×
Q2 FY1628 Oct 2015-1.0%-7.3%-3.2%0.9×
Q1 FY163 Aug 2015+0.6%-7.7%-28.2%2.8×
Q4 FY153 Jun 2015-1.9%-3.4%+17.8%1.7×
Q3 FY154 Feb 2015+5.0%+7.3%+16.9%1.2×
Q2 FY154 Nov 2014+5.0%+7.4%+9.1%4.7×
Q1 FY1521 Aug 2014-3.0%-8.7%-2.2%0.4×
Q4 FY149 Jun 2014-0.9%-0.4%+52.4%1.5×
Average-1.4%-3.5%-1.1%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q1 FY27

CSV
Revenue YoY+15.8%
Profit YoY-13.5%
Interest cost YoY+49.1%
Revenue QoQ+536.5%
Profit QoQ—
CAGR2Y3Y4Y5Y6Y7Y
Revenue+19.8%—————
Profit-6.5%—————

Key data

CSV
Open138.50
Day range136.00 – 141.98
52-week range126.15 – 204.00
From 52w high-32.2%
RSI (14)34.9
ATR (14)5.69
Volume9.3K
Avg volume (20D)26.7K
Rel volume0.35×
Volatility (1Y)37.2%
Turnover₹12.8L
SMA 50 / 200152.75 / 156.23

Delivery percentage

Latest · 6 Oct 202668.4%
20-day avg79.4%
1-year avg67.2%
Percentile (own history)66th
Range14.1–100.0%
Sessions1,731

Over the last 20 sessions NATHBIOGEN settled 79.4% of its traded quantity, which is unusually high for an NSE equity. Its one-year average is 67.2%, so recent sessions are running 12.1 points higher than usual. The latest session ranks higher than 66% of the 1,731 sessions on record for it.

What delivery percentage measuresScan the whole market on delivery

IndustryOther Agricultural Products

Performance returns

CSV
1D1W1M3M6M1Y
Price+2.99%-4.03%-9.64%-17.94%-1.75%-16.86%

Valuation

CSV
Market cap₹263 Cr
P/E (TTM)7.2
EPS (TTM)19.26
Shares outstanding1.90Cr
Listed28 Jan 2014

Ownership

CSV
Promoter45.60%
Promoter Δ QoQ0.00 pp
Public54.40%
FII0.27%
DII0.01%
Pledged13.78%

Quarterly results · consolidated

CSV
Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue (₹ Cr)43.866.051.6328.4
YoY chg+36.2%+78.9%-0.7%+15.8%
Net profit (₹ Cr)2.81.6(0.0)32.3
YoY chg+147.3%-39.4%-100.6%-13.5%
Net margin6.3%2.4%-0.0%9.8%
EPS1.400.84-0.7916.98

Shareholding over time

CSV

By quarter

30 Jun 2026 · promoter 45.60% · public 54.40%
30 Jun 2021: promoter 41.03%30 Sept 2021: promoter 41.03%31 Dec 2021: promoter 41.03%31 Mar 2022: promoter 41.05%30 Jun 2022: promoter 41.07%30 Sept 2022: promoter 45.60%31 Dec 2022: promoter 45.60%31 Mar 2023: promoter 45.60%30 Jun 2023: promoter 45.60%30 Sept 2023: promoter 45.60%31 Dec 2023: promoter 45.60%31 Mar 2024: promoter 45.60%30 Jun 2024: promoter 45.60%30 Sept 2024: promoter 45.60%31 Dec 2024: promoter 45.60%31 Mar 2025: promoter 45.60%30 Jun 2025: promoter 45.60%30 Sept 2025: promoter 45.60%31 Dec 2025: promoter 45.60%31 Mar 2026: promoter 45.60%30 Jun 2026: promoter 45.60%
2021-062026-06
  • Promoter
  • Public and others
Promoter
45.60%
Public
54.40%
Promoter change
0.00 pp
Filed
21 Jul 2026
FII
0.27%
DII
0.01%
Promoter pledged
13.78%

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional and pledge figures come from a separate filing stage whose backfill is still running, so they are absent for almost every instrument rather than zero.

Financials · quarterly statement

CSV
₹ crore, as filed
 Q2 FY24Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25AQ1 FY26Q2 FY26Q3 FY26Q4 FY26AQ1 FY27
Revenue from operations22.631.743.0243.932.236.952.0283.743.866.051.6328.4
Other income0.10.00.40.10.10.53.91.81.91.72.41.9
Total income22.631.843.4244.032.337.455.8285.545.867.754.0330.3
Total expenses20.329.741.2210.431.233.654.3249.642.467.952.7298.5
└ Finance costs2.42.81.12.23.03.91.43.23.74.54.64.3
└ Depreciation0.80.81.00.80.80.81.31.01.01.01.01.0
Profit before tax2.44.63.233.61.13.82.137.95.52.52.533.0
Tax expense0.30.80.60.2(0.0)1.10.60.70.60.92.50.7
Net profit2.13.82.633.41.12.71.537.32.81.6(0.0)32.3
EPS0.862.021.8717.490.531.331.1419.581.400.84-0.7916.98
Net margin9.16%12.08%6.08%13.68%3.46%7.19%2.85%13.14%6.28%2.43%-0.02%9.82%
PBT margin10.54%14.45%7.51%13.78%3.37%10.28%4.06%13.37%12.45%3.76%4.83%10.04%
Tax rate14.51%16.70%19.02%0.73%-2.53%30.07%29.75%1.74%11.75%35.22%100.37%2.19%

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. A quarterly filing carries a profit and loss only — there is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure here. Latest filed 29 Jul 2026.

NATHBIOGEN at a glance

  • NATHBIOGEN closed at ₹138.31 on 6 Oct 2026, +2.99% on the day, -16.9% over one year, 32.2% below its 52-week high of ₹204.
  • Delivery was 68.4% of traded quantity on 6 Oct 2026, the 66th percentile of its own 1,731 sessions with a reading (20-session average 79.4%, 1-year average 67.2%).
  • Market capitalisation is ₹263 crore at a trailing P/E of 7.2 (trailing EPS ₹19.26).
  • Q1 FY27 results (consolidated, filed 29 Jul 2026): revenue ₹328 crore (+15.8% year on year), net profit ₹32 crore (-13.5%); the price moved +0.9% on the first session after.
  • Promoters held 45.60% at 30 Jun 2026, unchanged on the previous filing, with 13.78% of promoter shares pledged.
  • Q2 FY27 results are expected between 16 Oct 2026 and 13 Nov 2026, going by past filing dates — an estimate, not an announcement.